According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ10.36. In 2016 the company made an earnings per share (EPS) of -ยฃ9.14 an increase over its 2015 EPS that were of -ยฃ9.87.